{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:17Z","timestamp":1786979777261,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017SXEXT5"],"award-info":[{"award-number":["2017SXEXT5"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["\u201cGruppi di ricerca 2020\u201d grant # PROT. A0375-2020-36550"],"award-info":[{"award-number":["\u201cGruppi di ricerca 2020\u201d grant # PROT. A0375-2020-36550"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00213-022-06286-3","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T08:05:20Z","timestamp":1670227520000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome"],"prefix":"10.1007","volume":"240","author":[{"given":"Valeria","family":"Buzzelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia V.","family":"Perederiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle H.","family":"Ambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Hausman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-6045","authenticated-orcid":false,"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"6286_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS (2019) A synaptic perspective of Fragile X syndrome and autism spectrum disorders. Neuron 101:1070\u20131088","journal-title":"Neuron"},{"key":"6286_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406010751","volume":"8","author":"B Bardoni","year":"2006","unstructured":"Bardoni B, Davidovic L, Bensaid M, Khandjian EW (2006) The Fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8:1\u201316","journal-title":"Expert Rev Mol Med"},{"key":"6286_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","volume":"142","author":"SJ Belouin","year":"2018","unstructured":"Belouin SJ, Henningfield JE (2018) Psychedelics: where we are now, why we got here, what we must do. Neuropharmacology 142:7\u201319","journal-title":"Neuropharmacology"},{"key":"6286_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2040-2392-4-16","volume":"4","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Chen CF, Pittman AR, Skinner CD, McCartney HJ, Jones K, Bochner BR, Stevenson RE, Schwartz CE (2013) Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism 4:16","journal-title":"Mol Autism"},{"key":"6286_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnbeh.2019.00023","volume":"13","author":"M Borsoi","year":"2019","unstructured":"Borsoi M, Manduca A, Bara A, Lassalle O, Pelissier-Alicot AL, Manzoni OJ (2019) Sex differences in the behavioral and synaptic consequences of a single in vivo exposure to the synthetic cannabimimetic WIN55,212\u20132 at puberty and adulthood. Front Behav Neurosci 13:23","journal-title":"Front Behav Neurosci"},{"key":"6286_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0269881114531666","volume":"28","author":"T Buchborn","year":"2014","unstructured":"Buchborn T, Schroder H, Hollt V, Grecksch G (2014) Repeated lysergic acid diethylamide in an animal model of depression: normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling. J Psychopharmacol 28:545\u2013552","journal-title":"J Psychopharmacol"},{"issue":"1","key":"6286_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2022","unstructured":"Calder AE, Hasler G (2022) Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48(1):104\u2013112","journal-title":"Neuropsychopharmacology"},{"key":"6286_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Benson CJ, Dunlap LE, Olson DE (2018) Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci 9:1582\u20131590","journal-title":"ACS Chem Neurosci"},{"issue":"Suppl 2","key":"6286_CR9","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/sj.mp.4001167","volume":"7","author":"DC Chugani","year":"2002","unstructured":"Chugani DC (2002) Role of altered brain serotonin mechanisms in autism. Mol Psychiatry 7(Suppl 2):S16\u2013S17","journal-title":"Mol Psychiatry"},{"key":"6286_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/mrdd.20021","volume":"10","author":"DC Chugani","year":"2004","unstructured":"Chugani DC (2004) Serotonin in autism and pediatric epilepsies. Ment Retard Dev Disabil Res Rev 10:112\u2013116","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"6286_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D","volume":"28","author":"DC Chugani","year":"1998","unstructured":"Chugani DC, Muzik O, Chakraborty P, Mangner T, Chugani HT (1998) Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse 28:33\u201343","journal-title":"Synapse"},{"key":"6286_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fnmol.2018.00353","volume":"11","author":"L Costa","year":"2018","unstructured":"Costa L, Sardone LM, Bonaccorso CM, D\u2019Antoni S, Spatuzza M, Gulisano W, Tropea MR, Puzzo D, Leopoldo M, Lacivita E, Catania MV, Ciranna L (2018) Activation of serotonin 5-HT7 receptors modulates hippocampal synaptic plasticity by stimulation of adenylate cyclases and rescues learning and behavior in a mouse model of Fragile X syndrome. Front Mol Neurosci 11:353","journal-title":"Front Mol Neurosci"},{"key":"6286_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnbeh.2015.00065","volume":"9","author":"L Costa","year":"2015","unstructured":"Costa L, Sardone LM, Lacivita E, Leopoldo M, Ciranna L (2015) Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X syndrome. Front Behav Neurosci 9:65","journal-title":"Front Behav Neurosci"},{"issue":"2","key":"6286_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/ijms21020505","volume":"21","author":"M Crispino","year":"2020","unstructured":"Crispino M, Volpicelli F, Perrone-Capano C (2020) Role of the serotonin receptor 7 in brain plasticity: from development to disease. Int J Mol Sci 21(2):505","journal-title":"Int J Mol Sci"},{"key":"6286_CR15","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/nn.3379","volume":"16","author":"JC Darnell","year":"2013","unstructured":"Darnell JC, Klann E (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 16:1530\u20131536","journal-title":"Nat Neurosci"},{"key":"6286_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","volume":"78","author":"AK Davis","year":"2021","unstructured":"Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR (2021) Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiat 78:481\u2013489","journal-title":"JAMA Psychiat"},{"key":"6286_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tig.2017.07.008","volume":"33","author":"JK Davis","year":"2017","unstructured":"Davis JK, Broadie K (2017) Multifarious functions of the Fragile X mental retardation protein. Trends Genet 33:703\u2013714","journal-title":"Trends Genet"},{"key":"6286_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","volume":"41","author":"D De Gregorio","year":"2021","unstructured":"De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G (2021) Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. J Neurosci 41:891\u2013900","journal-title":"J Neurosci"},{"key":"6286_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbr.2014.05.046","volume":"271","author":"Q Ding","year":"2014","unstructured":"Ding Q, Sethna F, Wang H (2014) Behavioral analysis of male and female Fmr1 knockout mice on C57BL\/6 background. Behav Brain Res 271:72\u201378","journal-title":"Behav Brain Res"},{"key":"6286_CR20","unstructured":"Fadiman J (2011) The psychedelic explorer\u2019s guide: Safe, therapeutic, and sacred journeys. Inner Traditions Bear and Company"},{"key":"6286_CR21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1073\/pnas.1918477117","volume":"117","author":"M Forstmann","year":"2020","unstructured":"Forstmann M, Yudkin DA, Prosser AMB, Heller SM, Crockett MJ (2020) Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proc Natl Acad Sci USA 117:2338\u20132346","journal-title":"Proc Natl Acad Sci USA"},{"key":"6286_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","volume":"20","author":"H Gill","year":"2020","unstructured":"Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS (2020) The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Rev Neurother 20:1263\u20131273","journal-title":"Expert Rev Neurother"},{"key":"6286_CR23","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/cercor\/bhz029","volume":"29","author":"CEM Golden","year":"2019","unstructured":"Golden CEM, Breen MS, Koro L, Sonar S, Niblo K, Browne A, Burlant N, Di Marino D, De Rubeis S, Baxter MG, Buxbaum JD, Harony-Nicolas H (2019) Deletion of the KH1 domain of Fmr1 leads to transcriptional alterations and attentional deficits in rats. Cereb Cortex 29:2228\u20132244","journal-title":"Cereb Cortex"},{"key":"6286_CR24","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ (2017) Fragile X syndrome. Nat Rev Dis Primers 3:17065","journal-title":"Nat Rev Dis Primers"},{"key":"6286_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1542\/peds.2008-0317","volume":"123","author":"RJ Hagerman","year":"2009","unstructured":"Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M (2009) Advances in the treatment of Fragile X syndrome. Pediatrics 123:378\u2013390","journal-title":"Pediatrics"},{"key":"6286_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","volume":"12","author":"RJ Hagerman","year":"2016","unstructured":"Hagerman RJ, Hagerman P (2016) Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol 12:403\u2013412","journal-title":"Nat Rev Neurol"},{"key":"6286_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5582\/irdr.2014.01027","volume":"3","author":"AC Hanson","year":"2014","unstructured":"Hanson AC, Hagerman RJ (2014) Serotonin dysregulation in Fragile X syndrome: implications for treatment. Intractable Rare Dis Res 3:110\u2013117","journal-title":"Intractable Rare Dis Res"},{"key":"6286_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1352\/2008.113:427-438","volume":"113","author":"SW Harris","year":"2008","unstructured":"Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ (2008) Autism profiles of males with Fragile X syndrome. Am J Ment Retard 113:427\u2013438","journal-title":"Am J Ment Retard"},{"key":"6286_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology 172:145\u2013156","journal-title":"Psychopharmacology"},{"key":"6286_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ajmg.a.32848","volume":"149A","author":"RN Hernandez","year":"2009","unstructured":"Hernandez RN, Feinberg RL, Vaurio R, Passanante NM, Thompson RE, Kaufmann WE (2009) Autism spectrum disorder in Fragile X syndrome: a longitudinal evaluation. Am J Med Genet A 149A:1125\u20131137","journal-title":"Am J Med Genet A"},{"key":"6286_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10803-007-0365-5","volume":"38","author":"D Hessl","year":"2008","unstructured":"Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman RJ (2008) Brief report: aggression and stereotypic behavior in males with Fragile X syndrome\u2013moderating secondary genes in a \u201csingle gene\u201d disorder. J Autism Dev Disord 38:184\u2013189","journal-title":"J Autism Dev Disord"},{"key":"6286_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","volume":"11","author":"M Hibicke","year":"2020","unstructured":"Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD (2020) Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Chem Neurosci 11:864\u2013871","journal-title":"ACS Chem Neurosci"},{"key":"6286_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.640241","volume":"12","author":"GA Higgins","year":"2021","unstructured":"Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM (2021) Low doses of psilocybin and ketamine enhance motivation and attention in poor performing rats: evidence for an antidepressant property. Front Pharmacol 12:640241","journal-title":"Front Pharmacol"},{"key":"6286_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S0033291718002283","volume":"49","author":"MJ Hollocks","year":"2019","unstructured":"Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS (2019) Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med 49:559\u2013572","journal-title":"Psychol Med"},{"key":"6286_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","volume":"29","author":"RR Horsley","year":"2018","unstructured":"Horsley RR, Palenicek T, Kolin J, Vales K (2018) Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats. Behav Pharmacol 29:530\u2013536","journal-title":"Behav Pharmacol"},{"key":"6286_CR36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41598-021-81446-7","volume":"11","author":"LS Kaertner","year":"2021","unstructured":"Kaertner LS, Steinborn MB, Kettner H, Spriggs MJ, Roseman L, Buchborn T, Balaet M, Timmermann C, Erritzoe D, Carhart-Harris RL (2021) Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing. Sci Rep 11:1941","journal-title":"Sci Rep"},{"key":"6286_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412","journal-title":"PLoS Biol"},{"key":"6286_CR38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/gbb.12071","volume":"12","author":"MK King","year":"2013","unstructured":"King MK, Jope RS (2013) Lithium treatment alleviates impaired cognition in a mouse model of Fragile X syndrome. Genes Brain Behav 12:723\u2013731","journal-title":"Genes Brain Behav"},{"key":"6286_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0269881119857204","volume":"33","author":"KP Kuypers","year":"2019","unstructured":"Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) Microdosing psychedelics: more questions than answers? An overview and suggestions for future research. J Psychopharmacol 33:1039\u20131057","journal-title":"J Psychopharmacol"},{"key":"6286_CR40","doi-asserted-by":"publisher","first-page":"204512532095056","DOI":"10.1177\/2045125320950567","volume":"10","author":"KPC Kuypers","year":"2020","unstructured":"Kuypers KPC (2020) The therapeutic potential of microdosing psychedelics in depression. Ther Adv Psychopharmacol 10:2045125320950567","journal-title":"Ther Adv Psychopharmacol"},{"key":"6286_CR41","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai MC, Lombardo MV, Baron-Cohen S (2014) Autism. Lancet 383:896\u2013910","journal-title":"Lancet"},{"key":"6286_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000118465","volume":"20","author":"JM Launay","year":"1988","unstructured":"Launay JM, Ferrari P, Haimart M, Bursztejn C, Tabuteau F, Braconnier A, Pasques-Bondoux D, Luong C, Dreux C (1988) Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiology 20:1\u201311","journal-title":"Neuropsychobiology"},{"key":"6286_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.008","volume":"75","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H, Schecke H, Klein M (2020) Microdosing psychedelics: motivations, subjective effects and harm reduction. Int J Drug Policy 75:102600","journal-title":"Int J Drug Policy"},{"key":"6286_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuron.2012.09.013","volume":"76","author":"KP Lesch","year":"2012","unstructured":"Lesch KP, Waider J (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76:175\u2013191","journal-title":"Neuron"},{"issue":"10","key":"6286_CR45","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/molecules26102948","volume":"26","author":"H Lowe","year":"2021","unstructured":"Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L (2021) The therapeutic potential of psilocybin. Molecules 26(10):2948","journal-title":"Molecules"},{"key":"6286_CR46","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1523\/JNEUROSCI.3516-16.2017","volume":"37","author":"A Manduca","year":"2017","unstructured":"Manduca A, Bara A, Larrieu T, Lassalle O, Joffre C, Laye S, Manzoni OJ (2017) Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acid imbalance. J Neurosci 37:6851\u20136868","journal-title":"J Neurosci"},{"key":"6286_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.749068","volume":"12","author":"A Markopoulos","year":"2021","unstructured":"Markopoulos A, Inserra A, De Gregorio D, Gobbi G (2021) Evaluating the potential use of serotonergic psychedelics in autism spectrum disorder. Front Pharmacol 12:749068","journal-title":"Front Pharmacol"},{"key":"6286_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.03.013","volume":"83","author":"DA Martin","year":"2014","unstructured":"Martin DA, Marona-Lewicka D, Nichols DE, Nichols CD (2014) Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia. Neuropharmacology 83:1\u20138","journal-title":"Neuropharmacology"},{"key":"6286_CR49","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1111\/bph.14435","volume":"175","author":"F Melancia","year":"2018","unstructured":"Melancia F, Schiavi S, Servadio M, Cartocci V, Campolongo P, Palmery M, Pallottini V, Trezza V (2018) Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. Br J Pharmacol 175:3699\u20133712","journal-title":"Br J Pharmacol"},{"key":"6286_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2018.04.042","volume":"350","author":"F Melancia","year":"2018","unstructured":"Melancia F, Trezza V (2018) Modelling Fragile X syndrome in the laboratory setting: a behavioral perspective. Behav Brain Res 350:149\u2013163","journal-title":"Behav Brain Res"},{"key":"6286_CR51","doi-asserted-by":"crossref","unstructured":"Mollinedo-Gajate I, Song C, Sintes-Rodriguez M, Whela T, Soula A, Selimbeyoglu A, Hurley S, Kn\u00f6pfel T (2020) Psilocybin rescues sociability deficits in an animal model of autism. bioRxiv","DOI":"10.1101\/2020.09.09.289348"},{"key":"6286_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","volume":"321","author":"CL Muller","year":"2016","unstructured":"Muller CL, Anacker AMJ, Veenstra-VanderWeele J (2016) The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 321:24\u201341","journal-title":"Neuroscience"},{"key":"6286_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","volume":"181","author":"D Nutt","year":"2020","unstructured":"Nutt D, Erritzoe D, Carhart-Harris R (2020) Psychedelic psychiatry\u2019s brave new world. Cell 181:24\u201328","journal-title":"Cell"},{"key":"6286_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neubiorev.2020.09.035","volume":"119","author":"G Ona","year":"2020","unstructured":"Ona G, Bouso JC (2020) Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: a systematic review. Neurosci Biobehav Rev 119:194\u2013203","journal-title":"Neurosci Biobehav Rev"},{"key":"6286_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","volume":"14","author":"T Passie","year":"2008","unstructured":"Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A (2008) The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther 14:295\u2013314","journal-title":"CNS Neurosci Ther"},{"key":"6286_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","volume":"7","author":"T Passie","year":"2002","unstructured":"Passie T, Seifert J, Schneider U, Emrich HM (2002) The pharmacology of psilocybin. Addict Biol 7:357\u2013364","journal-title":"Addict Biol"},{"key":"6286_CR57","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","volume":"20","author":"T Pokorny","year":"2017","unstructured":"Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX (2017) Effect of psilocybin on empathy and moral decision-making. Int J Neuropsychopharmacol 20:747\u2013757","journal-title":"Int J Neuropsychopharmacol"},{"key":"6286_CR58","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1073\/pnas.1524187113","volume":"113","author":"KH Preller","year":"2016","unstructured":"Preller KH, Pokorny T, Hock A, Kraehenmann R, Stampfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016) Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing. Proc Natl Acad Sci USA 113:5119\u20135124","journal-title":"Proc Natl Acad Sci USA"},{"key":"6286_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fnbeh.2014.00180","volume":"8","author":"L Rambousek","year":"2014","unstructured":"Rambousek L, Palenicek T, Vales K, Stuchlik A (2014) The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat. Front Behav Neurosci 8:180","journal-title":"Front Behav Neurosci"},{"key":"6286_CR60","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165\u20131180","journal-title":"J Psychopharmacol"},{"key":"6286_CR61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJH Rucker","year":"2018","unstructured":"Rucker JJH, Iliff J, Nutt DJ (2018) Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology 142:200\u2013218","journal-title":"Neuropharmacology"},{"key":"6286_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1248\/bpb.b14-00315","volume":"38","author":"Y Sakashita","year":"2015","unstructured":"Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I, Horiguchi Y, Taguchi K (2015) Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats. Biol Pharm Bull 38:134\u2013138","journal-title":"Biol Pharm Bull"},{"key":"6286_CR63","doi-asserted-by":"publisher","unstructured":"Schiavi S, Iezzi D, Manduca A, Leone S, Melancia F, Carbone C, Petrella M, Mannaioni G, Masi A, Trezza V (2019) Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to valproic acid. Front Cell Neurosci 13:479. https:\/\/doi.org\/10.3389\/fncel.2019.00479","DOI":"10.3389\/fncel.2019.00479"},{"key":"6286_CR64","doi-asserted-by":"crossref","unstructured":"Schiavi S, Carbone E, Melancia F, Buzzelli V, Manduca A, Campolongo P, Pallottini V, Trezza V (2022a) Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats. Nutr Neurosci 25:898\u2013911","DOI":"10.1080\/1028415X.2020.1819107"},{"key":"6286_CR65","doi-asserted-by":"publisher","unstructured":"Schiavi S, Manduca A, Carbone E, Buzzelli V, Rava A, Feo A, Ascone F, Morena M, Campolongo P, Hill MN, Trezza V. (2022b) Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats. Neuropsychopharmacology. https:\/\/doi.org\/10.1038\/s41386-022-01454-7","DOI":"10.1038\/s41386-022-01454-7"},{"key":"6286_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s42003-020-0791-x","volume":"3","author":"Y Schill","year":"2020","unstructured":"Schill Y, Bijata M, Kopach O, Cherkas V, Abdel-Galil D, Bohm K, Schwab MH, Matsuda M, Compan V, Basu S, Bijata K, Wlodarczyk J, Bard L, Cole N, Dityatev A, Zeug A, Rusakov DA, Ponimaskin E (2020) Serotonin 5-HT4 receptor boosts functional maturation of dendritic spines via RhoA-dependent control of F-actin. Commun Biol 3:76","journal-title":"Commun Biol"},{"key":"6286_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.euroneuro.2017.11.014","volume":"28","author":"M Servadio","year":"2018","unstructured":"Servadio M, Manduca A, Melancia F, Leboffe L, Schiavi S, Campolongo P, Palmery M, Ascenzi P, di Masi A, Trezza V (2018) Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid. Eur Neuropsychopharmacol 28:85\u201396","journal-title":"Eur Neuropsychopharmacol"},{"key":"6286_CR68","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"LX Shao","year":"2021","unstructured":"Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC (2021) Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109:2535-2544 e4","journal-title":"Neuron"},{"key":"6286_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","volume":"196","author":"L Smigielski","year":"2019","unstructured":"Smigielski L, Scheidegger M, Kometer M, Vollenweider FX (2019) Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage 196:207\u2013215","journal-title":"Neuroimage"},{"key":"6286_CR70","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/jnc.13962","volume":"141","author":"L Speranza","year":"2017","unstructured":"Speranza L, Labus J, Volpicelli F, Guseva D, Lacivita E, Leopoldo M, Bellenchi GC, di Porzio U, Bijata M, Perrone-Capano C, Ponimaskin E (2017) Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons. J Neurochem 141:647\u2013661","journal-title":"J Neurochem"},{"key":"6286_CR71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2019.04.012","volume":"110","author":"T Takumi","year":"2020","unstructured":"Takumi T, Tamada K, Hatanaka F, Nakai N, Bolton PF (2020) Behavioral neuroscience of autism. Neurosci Biobehav Rev 110:60\u201376","journal-title":"Neurosci Biobehav Rev"},{"key":"6286_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.12.024","volume":"159","author":"AM Tartaglione","year":"2019","unstructured":"Tartaglione AM, Schiavi S, Calamandrei G, Trezza V (2019) Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder. Neuropharmacology 159:107477","journal-title":"Neuropharmacology"},{"key":"6286_CR73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnmol.2017.00269","volume":"10","author":"Y Tian","year":"2017","unstructured":"Tian Y, Yang C, Shang S, Cai Y, Deng X, Zhang J, Shao F, Zhu D, Liu Y, Chen G, Liang J, Sun Q, Qiu Z, Zhang C (2017) Loss of FMRP impaired hippocampal long-term plasticity and spatial learning in rats. Front Mol Neurosci 10:269","journal-title":"Front Mol Neurosci"},{"key":"6286_CR74","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1093\/hmg\/ddv299","volume":"24","author":"SM Till","year":"2015","unstructured":"Till SM, Asiminas A, Jackson AD, Katsanevaki D, Barnes SA, Osterweil EK, Bear MF, Chattarji S, Wood ER, Wyllie DJ, Kind PC (2015) Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS. Hum Mol Genet 24:5977\u20135984","journal-title":"Hum Mol Genet"},{"key":"6286_CR75","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/FBP.0000000000000198","volume":"27","author":"F Tyls","year":"2016","unstructured":"Tyls F, Palenicek T, Kaderabek L, Lipski M, Kubesova A, Horacek J (2016) Sex differences and serotonergic mechanisms in the behavioural effects of psilocin. Behav Pharmacol 27:309\u2013320","journal-title":"Behav Pharmacol"},{"key":"6286_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00008877-200409000-00018","volume":"15","author":"R Ventura","year":"2004","unstructured":"Ventura R, Pascucci T, Catania MV, Musumeci SA, Puglisi-Allegra S (2004) Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15:433\u2013442","journal-title":"Behav Pharmacol"},{"key":"6286_CR77","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/sj.npp.1301324","volume":"32","author":"FX Vollenweider","year":"2007","unstructured":"Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB (2007) The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology 32:1876\u201387","journal-title":"Neuropsychopharmacology"},{"key":"6286_CR78","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 11:642\u2013651","journal-title":"Nat Rev Neurosci"},{"key":"6286_CR79","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11920-018-0949-0","volume":"20","author":"SW White","year":"2018","unstructured":"White SW, Simmons GL, Gotham KO, Conner CM, Smith IC, Beck KB, Mazefsky CA (2018) Psychosocial treatments targeting anxiety and depression in adolescents and adults on the autism spectrum: review of the latest research and recommended future directions. Curr Psychiatry Rep 20:82","journal-title":"Curr Psychiatry Rep"},{"key":"6286_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pneurobio.2016.03.007","volume":"151","author":"A Wirth","year":"2017","unstructured":"Wirth A, Holst K, Ponimaskin E (2017) How serotonin receptors regulate morphogenic signalling in neurons. Prog Neurobiol 151:35\u201356","journal-title":"Prog Neurobiol"},{"key":"6286_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-4939-9080-1_15","volume":"1942","author":"M Zafarullah","year":"2019","unstructured":"Zafarullah M, Tassone F (2019) Fragile X-associated tremor\/ataxia syndrome (FXTAS). Methods Mol Biol 1942:173\u2013189","journal-title":"Methods Mol Biol"},{"key":"6286_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphar.2015.00225","volume":"6","author":"G Zhang","year":"2015","unstructured":"Zhang G, Stackman RW Jr (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 6:225","journal-title":"Front Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T08:45:53Z","timestamp":1701506753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6286"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06286-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742437215.793597073","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, and Viviana Trezza have no conflict of interest. Julia V. Perederiy, Kyle H. Ambert, and Marvin Hausman are employees of NOVA MENTIS Life Science Corp.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}